HilleVax Balance Sheet Health
Financial Health criteria checks 5/6
HilleVax has a total shareholder equity of $265.5M and total debt of $25.2M, which brings its debt-to-equity ratio to 9.5%. Its total assets and total liabilities are $344.4M and $78.9M respectively.
Key information
9.5%
Debt to equity ratio
US$25.24m
Debt
Interest coverage ratio | n/a |
Cash | US$303.48m |
Equity | US$265.53m |
Total liabilities | US$78.91m |
Total assets | US$344.43m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: HLVX's short term assets ($310.7M) exceed its short term liabilities ($29.3M).
Long Term Liabilities: HLVX's short term assets ($310.7M) exceed its long term liabilities ($49.6M).
Debt to Equity History and Analysis
Debt Level: HLVX has more cash than its total debt.
Reducing Debt: Insufficient data to determine if HLVX's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: HLVX has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: HLVX has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 65.3% each year.